| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
4; author reply 2534 |
| issn |
0003-9926 |
| issueIdentifier |
20 |
| pageRange |
2533-4; author reply 2534 |
| publicationName |
Archives of Internal Medicine |
| startingPage |
2533 |
| bibliographicCitation |
Peterson GM, Jackson SL. Cost-effectiveness of newer antiplatelet drugs. Arch Intern Med. 2003 Nov 10;163(20):2533–4; author reply 2534. doi: 10.1001/archinte.163.20.2533-b. PMID: 14609794. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbf3d2a826c86ca8fb44d0f036e60e65
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77db9ae24b29352070bf81f57a5884a8 |
| date |
2003-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/14609794
https://doi.org/10.1001/archinte.163.20.2533-b |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/767
https://portal.issn.org/resource/ISSN/0003-9926 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Cost-effectiveness of Newer Antiplatelet Drugs |
| discusses |
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0155432
http://id.nlm.nih.gov/mesh/M0001864 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D016527
http://id.nlm.nih.gov/mesh/D010975Q000191
http://id.nlm.nih.gov/mesh/D001241Q000191
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D013988Q000191 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D003362
http://id.nlm.nih.gov/mesh/D004359 |